The CISCRP Participant
Monthly Update
January 2007; Vol. 4 Issue 1

FEATURES

National Poll Shows That Relatively Few Americans Admire Clinical Trial Participants For Their Contribution To Medical Science


A recent national survey of 900 adults finds that only one-third of the public greatly admires people who participate in clinical trials. This compares with 84% who greatly admire organ donors and 68% who greatly admire those who donate blood. The survey, jointly conducted in mid-December 2006 by the independent non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP) and polling firm Opinion Dynamics Corporation (ODC) is the first survey to measure public recognition of the role that clinical research participants play in advancing medical science. For detailed results of the survey,
click here.
Continue...

Legislation filed to expand insurance companies' coverage of healthcare expenses for clinical research participants


Lack of coverage has been cited as a barrier for participating in a clinical trial. In one study, 60% of respondents cited a fear of having their insurance denied as the reason they decided not to participate in a trial. This can result in the patient not benefiting from a new therapy or treatment option. Determent from enrollment may also result in delaying the completion of a trial as a whole because of too few participants, potentially affecting a larger group from benefiting from those trial results.
Continue...

AWARE for All Heads South for the Winter


Having delivered three successful AWARE for All programs in 2006 (Boston, Indianapolis and Philadelphia), CISCRP continues to expand the program nationally with AWARE for All-Dallas scheduled for Saturday, March 31, 2007. AWARE-Dallas will be held in the Cityplace Conference Center located one-half mile north of downtown at 2711 North Haskell Avenue, Dallas from 9:00am to 2:30pm.
Continue...

Back to top

Thanks to our supporters

CISCRP would like to thank its 2006 Supporters for their generous contributions. Without their donations CISCRP would not have been able to: Expand the AWARE for All program nationally; create and launch the www.SearchClinicalTrials.org website; develop our new Public Service Announcement, which is about to be distributed to television stations across the country; distribute Education Before Participation brochures and dvds; establish the Educational Branding Initiative; provide speakers for conferences hosted by industry and non-profit organizations; conduct surveys and public opinion polls; serve as a resource for the media; and provide the public and patients with information about clinical research.

 
  • Acurian, Inc
  • Advocate Health Care
  • Altura 2000
  • American Cancer Society Southeast Region
  • American College of Radiology
  • American Diabetes Association
  • American Lung Associate of Indiana
  • Amgen
  • Anaclim
  • Association of Clinical Research Organizations
  • AstraZeneca
  • Aureus
  • Averion Inc.
  • Baker & Daniels
  • Benchmark Research
  • Beth Israel Deaconess Medical Center
  • Biocrossroads
  • Bioforce Solutions
  • Blue Cross Blue Shield of MA
  • Evan Brett
  • Bouve College of Health Sciences- Northeastern University
  • Burroughs Wellcome Fund
  • Caritas St. Elizabeth's Medical Center
  • Carolina Research Associates
  • Charlottesville Medical Research
  • Chesapeake Research Review, Inc.
  • Circle City ACRP
  • Clinical Research Center of Nevada
  • Clinical Research Group, Inc.
  • Community-Campus Partnerships for Health
  • Community Health Network
  • ConsentSolutions, INC
  • Cornea Research Foundation of America
  • Dana-Farber Cancer Institute
  • Diana Anderson LLP
  • Dovetail Associates
  • Drexel University School of Medicine
  • Duke Clinical Research Institute
  • Eli Lilly & Co
  • Essential Group. Inc
  • Fast4wd Ogilvy
  • Fast Search and Transfer
  • Fox Chase Cancer Center
  • Genesis Research International
  • Genetic Alliance
  • Genzyme
  • Ken Getz
  • Glaser Research Group, LTD
  • Dr. Harold Glass
  • Junius Gonzales
  • Harvard Pilgrim Health Care Foundation
  • Healthcare Communications Group
  • IntegReview, Inc. Ethical Review Board
  • Investigator Support Services, Inc.
  • Indiana University School of Medicine
  • IUPUI Conference Center
 
  • Kidney Cancer Association
  • Dr. Greg Koski
  • Jim Kremidas
  • Lupus Foundation of America, Inc.
  • Mass Association of Health Plans
  • Massachusetts General Hospital (MGH)
  • Massachusetts Medical Society
  • MdWise
  • Medifacts International
  • MedVadis Research
  • Merck & Co.
  • Methodist Research Institute of Inidianpolis
  • MGH Institute of Health Professions
  • Midwest Clinical Support, Inc.
  • New England Chapter of the ACRP
  • Newton-Wellesley Hospital
  • Nixon Peabody
  • Novartis Pharmaceuticals
  • Novo Nordisk, Inc
  • Ortho-McNeil Jannsen Pharmaceutical Services
  • Opinion Dynamics
  • Parkinson's Disease Foundation
  • Partners HealthCare Systems Inc.
  • PD Trials
  • Pfizer Global Research and Development
  • PharmaNet
  • Philadelphia Clinical Research LLC
  • PhRMA
  • PPD
  • Primary Care Cardiology Research Inc.
  • PRIMR
  • Promedica International
  • Pulmonary Associates of Richmond, Inc.
  • Quintiles
  • Radiant Research
  • Rapid Trials
  • Rochester Clinical Research Center
  • Rx Trials, Inc.
  • Sankyo Pharmaceuticals
  • SC Clinical Research Center, LLC
  • Shade Foundation
  • Shank Public Relations Counselors, Inc.
  • Spartanburg Medical Center
  • Stanford University
  • StatWorks, Inc.
  • Dr. Linda Strause
  • Sharon and Patrick Terry
  • Roni Thaler
  • Thomas Jefferson University
  • Trial Acceleration
  • Trial Minded
  • Tufts Health Plan
  • University of Pennsylvania School of Medicine
  • University of the Sciences- Philadelphia
  • Laura Watkins
  • Wyeth Pharmaceuticals
  • York Clinical Consulting


Back to top

Copyright © 2007 CISCRP. All Rights Reserved.